Does higher gadolinium concentration play a role in the morphologic assessment of brain tumors? Results of a multicenter intraindividual crossover comparison of gadobutrol versus gadobenate dimeglumine (the MERIT Study).
about
Optimizing contrast-enhanced magnetic resonance imaging characterization of brain metastases: relevance to stereotactic radiosurgery.Use of contrast agents in oncological imaging: magnetic resonance imaging.Compensatory biliary and urinary excretion of gadobenate ion after administration of gadobenate dimeglumine (MultiHance(®)) in cases of impaired hepatic or renal function: a mechanism that may aid in the prevention of nephrogenic systemic fibrosis?Dynamic and static magnetic resonance angiography of the supra-aortic vessels at 3.0 T: intraindividual comparison of gadobutrol, gadobenate dimeglumine, and gadoterate meglumine at equimolar dose.Multicenter, intra-individual comparison of single dose gadobenate dimeglumine and double dose gadopentetate dimeglumine for MR angiography of the peripheral arteries (the Peripheral VALUE Study).Gadolinium contrast agents for CNS imaging: current concepts and clinical evidence.Contrast-enhanced MR angiography: does a higher relaxivity MR contrast agent permit a reduction of the dose administered for routine vascular imaging applications?Multicenter, intraindividual comparison of single-dose gadobenate dimeglumine and double-dose gadopentetate dimeglumine for MR angiography of the supra-aortic arteries (the Supra-Aortic VALUE study).Gadobenate dimeglumine (MultiHance) in MR angiography: an in-vitro phantom comparison with gadopentetate dimeglumine (Magnevist) at different concentrations.Are there differences between macrocyclic gadolinium contrast agents for brain tumor imaging? Results of a multicenter intraindividual crossover comparison of gadobutrol with gadoteridol (the TRUTH study).Brain metastases: neuroimaging.The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study).Effectiveness of a high relaxivity contrast agent administered at half dose in dynamic susceptibility contrast MRI of brain gliomas.Pharmacokinetics of gadobenate dimeglumine in children 2 to 5 years of age undergoing MRI of the central nervous system.
P2860
Q30586979-8A6B3F12-6EB9-4F98-AEA2-8AAD44EE59DFQ30669419-51B99EE2-92EC-4A5D-B3DE-8AD391FF95F6Q36295407-638B8498-3DC2-47BF-B66D-FB6E8BBCB77BQ37282521-F1774FA4-8F9D-43B5-B21D-2AFB5BE2343DQ38078314-9224C949-4DEB-4339-8D42-1727F52D5F05Q38213840-F8B249C2-F7F5-45A2-B0C0-F68060F432D6Q40219525-8819D7AE-B782-48CF-8596-8AB0AB2A70A5Q45173741-65831014-6432-4478-BCF6-362B66274E9BQ46453502-1FE9FFA5-E783-40DB-86AF-D394C5DC72A0Q46805155-A9D10A83-B348-43AD-8F8E-CA81E02C8179Q47879878-600E8AEA-216A-45C8-BF92-7E2C3D594895Q48157270-DC3D81B3-CB7C-4AC8-B585-208704F968EAQ48177044-F36E5614-4D4A-4C9B-93E0-38469B4B0BC7Q48786983-01D1EE26-A6DD-40F1-B9B4-2786311D71B3
P2860
Does higher gadolinium concentration play a role in the morphologic assessment of brain tumors? Results of a multicenter intraindividual crossover comparison of gadobutrol versus gadobenate dimeglumine (the MERIT Study).
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Does higher gadolinium concent ...... dimeglumine (the MERIT Study).
@en
Does higher gadolinium concent ...... versus gadobenate dimeglumine
@nl
type
label
Does higher gadolinium concent ...... dimeglumine (the MERIT Study).
@en
Does higher gadolinium concent ...... versus gadobenate dimeglumine
@nl
prefLabel
Does higher gadolinium concent ...... dimeglumine (the MERIT Study).
@en
Does higher gadolinium concent ...... versus gadobenate dimeglumine
@nl
P2093
P2860
P356
P1476
Does higher gadolinium concent ...... dimeglumine (the MERIT Study).
@en
P2093
A Citterio
B Paraniak-Gieszczyk
C Colosimo
G Schneider
J Ruscalleda
P2860
P304
P356
10.3174/AJNR.A3033
P577
2012-03-01T00:00:00Z